tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Chen CH et al. Comparison of tuberculosis infection rates in a national database of renal transplant patients with data from a single center in Taiwan. 2014 Transplant. Proc. pmid:24656019
Grinyó JM and Petruzzelli S Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. 2014 Expert Rev Clin Immunol pmid:25407098
Hattori Y et al. Influence of cytochrome P450 3A5 polymorphisms on viral infection incidence in kidney transplant patients treated with tacrolimus. 2014 Transplant. Proc. pmid:24656015
Uchida J et al. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients. 2014 Transplant. Proc. pmid:24656005
Zaltzman JS et al. A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers. 2014 Transpl. Int. pmid:25160518
Misra DP et al. Pulmonary co-infection with Nocardia and Aspergillus in a patient with adult-onset Still's disease receiving steroids and tacrolimus. 2014 BMJ Case Rep pmid:25398925
Weng LC et al. Association between use of FK506 and prevalence of post-transplantation diabetes mellitus in kidney transplant patients. 2014 Transplant. Proc. pmid:24656004
Takahashi K et al. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan. 2014 Transplant. Proc. pmid:24655975
Cho JH et al. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. 2014 Eur J Pharm Sci pmid:24388864
Frassetto LA et al. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. 2014 Transplantation pmid:24389906
Hitzler JK et al. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. 2014 Pediatr Blood Cancer pmid:24391118
Zhang Y et al. Genome-wide identification and analysis of FK506-binding protein gene family in peach (Prunus persica). 2014 Gene pmid:24342662
Furian L et al. Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors. 2014 Transplant. Proc. pmid:25498057
Shin BH et al. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. 2014 Transplantation pmid:24342979
Shivaswamy V et al. Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats. 2014 Transl Res pmid:24361102
Cusinato DA et al. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. 2014 Br J Clin Pharmacol pmid:24528196
Gérard C et al. Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. 2014 AAPS J pmid:24526611
Leung EK et al. Clinical evaluation of the QMS® Tacrolimus immunoassay. 2014 Clin. Chim. Acta pmid:24518359
McCormack PL Extended-release tacrolimus: a review of its use in de novo kidney transplantation. 2014 Drugs pmid:25352392
Qi R et al. FK506 inhibits the mice glomerular mesangial cells proliferation by affecting the transforming growth factor-β and Smads signal pathways. 2014 Ren Fail pmid:24512120
Mocchegiani F et al. Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. 2014 Ann. Transplant. pmid:25347718
Filler G Finding the optimal therapeutic window for tacrolimus. 2014 Pediatr Transplant pmid:25345999
Pedroso JA et al. Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. 2014 Transplant. Proc. pmid:25242789
Torres IB et al. The Interplay between inflammation and fibrosis in kidney transplantation. 2014 Biomed Res Int pmid:24991565
Isoda K et al. The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. 2014 Intern. Med. pmid:24990333
Hu YM et al. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. 2014 J. Pharmacol. Exp. Ther. pmid:24610957
Wada A et al. Ribosome display and photo-cross-linking techniques for in vitro identification of target proteins of bioactive small molecules. 2014 Anal. Chem. pmid:24380432
Bäckman L and Persson CA An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. 2014 Ann. Transplant. pmid:24637379
Buendia JA et al. Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. 2014 Ther Drug Monit pmid:24378577
Mai HL et al. IL-7 receptor blockade following T cell depletion promotes long-term allograft survival. 2014 J. Clin. Invest. pmid:24569454
Eid L et al. Late acute rejection: incidence, risk factors, and effect on graft survival and function. 2014 Pediatr Transplant pmid:24372967
Peng ZG and Tian J Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients. 2014 Clin Transpl pmid:26281147
Tokuoka H et al. Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons. 2014 Neurosci. Lett. pmid:24291696
Filler G et al. Similar MPA exposure on modified release and regular tacrolimus. 2014 Ther Drug Monit pmid:24365986
Hancock WW Effects of histone deacetylase inhibitors on alloresponses. 2014 Lancet Oncol. pmid:24295573
Jain A et al. Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. 2014 Transplantation pmid:25285953
Czubkowski P et al. Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. 2014 Ann. Transplant. pmid:25409773
Guitard J et al. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. 2014 Clin. Nephrol. pmid:24040781
Protic M et al. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. 2014 J Crohns Colitis pmid:24908178
Hayashi K et al. Delayed false elevation of circulating tacrolimus concentrations after cord blood transplantation in a patient with myelodysplastic syndrome. 2014 Intern. Med. pmid:25400189
Spagnoletti G et al. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up. 2014 Transplant. Proc. pmid:25242756
Schellekens J et al. The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity? 2014 Transpl. Immunol. pmid:25240735
Sharp WW et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. 2014 FASEB J. pmid:24076965
Peng L et al. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. 2014 PLoS ONE pmid:25165975
Favennec C et al. Consideration of the switch from twice-daily to once-daily tacrolimus in pediatric kidney transplant in daily clinical practice: pharmacokinetic parameters, patient satisfaction and medical practices. 2014 Pediatr Transplant pmid:25164065
Gupta AK et al. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. 2014 PLoS ONE pmid:24819773
Hagihara Y et al. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. 2014 J Crohns Colitis pmid:24011513
Kilinc S et al. The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats. 2014 Int Urol Nephrol pmid:24014133
Gürkan A et al. Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. 2014 Arch. Oral Biol. pmid:24581850
Spasovski G and Masin-Spasovska J How to improve the survival of the kidney transplant - is it only the pharmaceutical management? 2014 Expert Opin Pharmacother pmid:24617949
Amanova A et al. Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. 2014 Clin Transplant pmid:25125128
Kim JS et al. Effects of FK-506 and CTLA4--Ig on nerve allografts in mice. 2014 J Plast Reconstr Aesthet Surg pmid:24120418
Schmid S et al. Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. 2014 Ann. Transplant. pmid:25123847
Caraveo G et al. Calcineurin determines toxic versus beneficial responses to α-synuclein. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25122673
Gajanayake T et al. A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. 2014 Sci Transl Med pmid:25122638
Thorat A et al. Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients. 2014 Biomed Res Int pmid:25121091
Griffith RD et al. Cells to surgery quiz: September 2014. 2014 J. Invest. Dermatol. pmid:25120152
Farkas K et al. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis. 2014 Expert Rev Gastroenterol Hepatol pmid:24738535
Li T et al. Effect of FK506 nanospheres on regeneration of allogeneic nerve after transplant. 2014 Asian Pac J Trop Med pmid:25066398
Hamilton BK and Kalaycio M Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis. 2014 Biol. Blood Marrow Transplant. pmid:25065905
Verghese PS et al. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. 2014 Nephrol. Dial. Transplant. pmid:24414376
Shimizu M et al. Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus. 2014 Rheumatology (Oxford) pmid:25065006
Da-Long S et al. Tacrolimus on Kimura's disease: a case report. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22939325
Dai YJ et al. Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris. 2014 Asian Pac J Trop Med pmid:25063291
Kyriakou A et al. Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature. 2014 Dermatology (Basel) pmid:24434685
Parvizi Z et al. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation. 2014 Mol. Biol. Rep. pmid:24996284
Al-Harbi NO et al. Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. 2014 Biomed Res Int pmid:24987695
Sun J et al. [A preliminary study on the biological characteristics and function of tolerogenic dendritic cells induced by tacrolimus]. 2014 Zhonghua Xue Ye Xue Za Zhi pmid:24985179
Saracino A et al. Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. 2014 Transplant. Proc. pmid:25242754
Lan X et al. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. 2014 World J. Gastroenterol. pmid:25232269
Fuchs U et al. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus. 2014 Ann. Transplant. pmid:24953848
Ji SM et al. Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results. 2014 Transplant. Proc. pmid:25498056
Elamin S et al. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits. 2014 Saudi J Kidney Dis Transpl pmid:24969193
Gibbs BF et al. Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates. 2014 J Biomed Nanotechnol pmid:24804546
Richards KR et al. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. 2014 Transplantation pmid:24784360
Cutler C et al. Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. 2014 Blood pmid:24982504
Hebral AL et al. Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen alloimmunization risk. 2014 Nephrol. Dial. Transplant. pmid:24914091
Zhu H et al. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo. 2014 Mol Med Rep pmid:24912495
Van Laecke S et al. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. 2014 Transpl. Int. pmid:24909487
Lin T et al. A Chinese girl with novel PLCE1 mutations and proliferation of the mesangium responded to tacrolimus therapy. 2014 Nephrology (Carlton) pmid:24533735
Trkulja V et al. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data. 2014 Ther Drug Monit pmid:24518562
Foroncewicz B et al. Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. 2014 Ann. Transplant. pmid:25163829
Hayashi T and Harada N Post-translational dual regulation of cytochrome P450 aromatase at the catalytic and protein levels by phosphorylation/dephosphorylation. 2014 FEBS J. pmid:25158681
Savikko J et al. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome. 2014 Transpl. Immunol. pmid:25158212
Akchurin OM et al. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. 2014 Pediatr Transplant pmid:24820521
Marin-Casino M et al. Significant tacrolimus and dronedarone interaction in a kidney transplant recipient. 2014 Transplantation pmid:25243519
Kern G et al. Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. 2014 PLoS ONE pmid:24816588
Sánchez L et al. Topical tacrolimus for recurrent penile Crohn's disease. 2014 J Crohns Colitis pmid:24815787
Kalkan G et al. An alternative treatment model: the combination therapy of narrow band ultraviolet B phototherapy and tacrolimus ointment 0.1% in biphasic amyloidosis. 2014 J Pak Med Assoc pmid:25272550
Reynolds BC et al. Use of belatacept to maintain adequate early immunosuppression in calcineurin-mediated microangiopathic hemolysis post-renal transplant. 2014 Pediatr Transplant pmid:24815506
Kim YE and Eun SC Effect of FK506 ointment (Protopic) on rat skin allograft model. 2014 Transplant. Proc. pmid:24815165
Wang J and Fan H [Assessment of P70S6 kinase phosphorylation after liver transplantation by phospho-flow cytometry]. 2014 Zhonghua Yi Xue Za Zhi pmid:25623311
Bergmann TK et al. Comparison of the influence of cyclosporine and tacrolimus on the pharmacokinetics of prednisolone in adult male kidney transplant recipients. 2014 Clin Drug Investig pmid:24385281
Osmola-Mańkowska A et al. Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography. 2014 Eur Rev Med Pharmacol Sci pmid:25555886
Lesche D et al. CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. 2014 Ther Drug Monit pmid:24739669
Hilgers M and Megahed M [Oral lichen planus. Insight into the pathogenesis and therapeutic options]. 2014 Hautarzt pmid:24722910
Shipkova M et al. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay. 2014 Clin. Biochem. pmid:24721684
Zhang X et al. Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry. 2014 J Chromatogr A pmid:25064533
Lin BW et al. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye. 2014 Invest. Ophthalmol. Vis. Sci. pmid:25491293
Hsiao FY and Hsu WW Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. 2014 Int Urol Nephrol pmid:24009082